Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

American journal of hematology - 1 Feb 2014

Barbui Tiziano, Thiele Jürgen, Carobbio Alessandra, Gisslinger Heinz, Finazzi Guido, Rumi Elisa, Luigia Randi Maria, Vannucchi Alessandro M, Gisslinger Bettina, Müllauer Leonhard, Ruggeri Marco, Rambaldi Alessandro, Tefferi Ayalew

Abstract excerpt

Polycythemia vera (PV) is currently diagnosed by the World Health Organization (WHO) criteria regarding hemoglobin (HB) levels and JAK2V617F and related mutations or by the British Committee for Standards in Haematology (BCSH) guidelines predominantly based on hematocrit (HCT) values (>52% in men and >48% in women) in JAK2 mutated patients. We examined clinical features at diagnosis and outcome in 397 mutated PV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Bone Marrow

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Erythrocyte Indices

Share to Janus Kinase 2

Share to Polycythemia Vera

Share to Risk Factors

Share to Young Adult

Source

Identifiers

PMID: 24166817
DOI: 10.1002/ajh.23617

Genes

JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Masked polycythemia vera diagnosed according to WHO and BCSH classification.PMID 24166817Read ↗

Masked polycythemia vera (mPV): results of an international study.Semantic proximity Read ↗

Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients.Semantic proximity Read ↗

Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes.Semantic proximity Read ↗

Polycythemia vera: from new, modified diagnostic criteria to new therapeutic approaches.Semantic proximity Read ↗

Low-hemoglobin Polycythemia Vera: Diagnostic Criteria and Clinico-pathological CharacterizationSemantic proximity Read ↗

Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.Semantic proximity Read ↗

Molecular Characterization of Polycythemia VeraSemantic proximity Read ↗

Polycythemia vera: diagnosis, clinical course, and current managementSemantic proximity Read ↗

Polycythemia vera.Semantic proximity Read ↗

Polycythaemia vera: molecular genetics, diagnostics and therapeutics.Semantic proximity Read ↗

European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.Semantic proximity Read ↗

Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC projectSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.